Subscribe To
Io biotech announces participation in upcoming investor conferences
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating...
September 6, 2023, 8:35 am
Pharvaris to present at the 18th german allergy congress
ZUG, Switzerland, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor ...
September 6, 2023, 6:51 am
Pharvaris to participate in the morgan stanley 21st annual global healthcare conference
ZUG, Switzerland, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a clinical-stage company developing novel, oral bradykinin-B2-receptor ...
September 6, 2023, 6:50 am
Verona pharma to present additional analysis of phase 3 enhance-1 study in copd at ers international congress 2023
Substantial reductions in rate and risk of exacerbations support potential of ensifentrine, an investigational, novel, selective, dual inhibitor of PD...
September 6, 2023, 2:00 am
Bolt biotherapeutics to participate in september investor conferences
REDWOOD CITY, Calif., Sept. 05, 2023 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics (Nasdaq: BOLT), a clinical-stage biopharmaceutical company developing ...
September 5, 2023, 4:15 pm
Tracon pharmaceuticals announces participation at upcoming investor conferences
SAN DIEGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cost...
September 5, 2023, 4:02 pm
Globally recognized expert in rare neurologic diseases, dr. michael levy, joins trethera scientific advisory board
LOS ANGELES, Sept. 05, 2023 (GLOBE NEWSWIRE) — Trethera Corporation, a clinical stage biopharmaceutical company committed to developing ...
September 5, 2023, 2:55 pm
Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb�...
September 5, 2023, 10:00 am
Zenas biopharma announces strategic license and collaboration agreement with bristol myers squibb to develop and commercialize novel bi-functional antibody obexelimab in japan, south korea, taiwan, si
Collaboration furthers Zenas’ vision to bring innovative immunology-based medicines to patients around the world by leveraging Bristol Myers Squibb�...
September 5, 2023, 10:00 am
Cns pharmaceuticals (nasdaq: cnsp) to present at the h.c. wainwright 25th annual global investment conference
Live webcast presentation on Wednesday, September 13th at 10:30 AM ET HOUSTON, TX / ACCESSWIRE / September 5, 2023 / CNS Pharmaceuticals, Inc. (NASDAQ...
September 5, 2023, 8:45 am
Harpoon therapeutics to host kol event in person and via webcast on september 15, 2023
KOLs to provide insight and discussion of HPN328 targeting SCLC, NEPC and other neuroendocrine tumors Abstract with HPN328 interim data accepted for p...
September 5, 2023, 8:05 am
Immutep: nipping at the heels of lag3.is it impressive enough?
Immutep Limited is a small cap biotech focusing on the development of eftilagimod alpha, a novel molecu...
September 1, 2023, 6:57 pm
Nexcella announces dr. suzanne lentzsch, director of the multiple myeloma and amyloidosis program at the college of physicians and surgeons of columbia university and at new york presbyterian hospital
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma and se...
September 1, 2023, 12:44 pm
Immix biopharma announces dr. suzanne lentzsch, director of the multiple myeloma and amyloidosis program at the college of physicians and surgeons of columbia university and at new york presbyterian h
Dr. Lentzsch joins the Nexcella Scientific Advisory Board with decades of experience treating patients with AL Amyloidosis and multiple myeloma and se...
September 1, 2023, 12:39 pm
Does revolut suffer from chatbot-based customer service?
The integration of technology has been a driving force behind innovation and ease in the dynamic domain of financial services. Chatbot-based customer ...
September 1, 2023, 7:17 am
Want to get rich? 3 game-changing metaverse stocks to buy right now
For investors who want to capitalize on, and immensely profit from, new trends in the market, they should look no further than the ...
September 1, 2023, 5:39 am
Janone to present in person and by video at h.c. wainwright's 25th annual global investment conference
Chief Medical Officer Dr. Amol Soin will discuss innovative approaches to pain management and JanOne's development of non-addicting treatments for pai...
August 31, 2023, 1:30 pm
Cerevance announces presentation at the 22nd society of chemical industry / royal society of chemistry medicinal chemistry symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel, pre...
August 31, 2023, 12:30 pm
Biomea fusion announces appointment of juan pablo frías, m.d. as chief medical officer
Industry veteran and prominent diabetes clinical development expert to oversee Biomea’s progressing clinical development of ...
August 31, 2023, 12:30 pm
Galecto to present at investor conferences in september
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin biology fo...
August 31, 2023, 11:00 am